Maternal serum endothelial cell-specific molecule-1 level and its correlation with severity of early-onset preeclampsia
| dc.authorid | 0000-0002-3765-8274 | |
| dc.authorid | 0000-0003-0234-3026 | |
| dc.contributor.author | Ovayolu, Ali | |
| dc.contributor.author | Karaman, Erbil | |
| dc.contributor.author | Turgut, Abdülkadir | |
| dc.contributor.author | Guler, Selver | |
| dc.contributor.author | Bostancieri, Nuray | |
| dc.date.accessioned | 2025-05-10T19:44:48Z | |
| dc.date.issued | 2021 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Preeclampsia (PE), the primary pathology of which is endothelial cell (EC) dysfunction, has long-lasting effects such as cardiovascular disease. Therefore, it was decided to investigate the maternal serum concentrations of EC-specific molecule-1 in patients with early-onset preeclampsia (E-PE). This study was conducted on 33 pregnant women with E-PE and 35 healthy pregnant women matched for gestational age. EC-specific molecule-1 level was measured using a commercially available enzyme-linked immunosorbent assay kit. The mean EC-specific molecule-1 concentrations were not significantly different between the groups (651.7 +/- 632.2 pg/mL vs. 425.9 +/- 263.0 pg/mL, p=.056). Among women with E-PE, the median EC-specific molecule-1 concentration did not differ significantly by disease severity (p=.115). EC-specific molecule-1 is not involved in the pathogenesis of E-PE. However, some studies in the literature report that EC-specific molecule-1 concentrations increased during the diagnosis of PE. Therefore, well-designed studies with a large sample are needed in cases of E-PE. Impact Statement What is already known on this subject? There is an increased risk of cardiovascular disease (CVD) in early-onset preeclampsia (E-PE) which is linked with endothelial dysfunction. Endothelial cell (EC)-specific molecule-1 stands out as an important marker in EC dysfunction related conditions such as preeclampsia. What the results of this study add? This study showed that EC-specific molecule-1 is not associated with the CVDs risk linked with endothelial dysfunction in E-PE. Additionally, there was also no significant relationship was detected between the severity of E-PE and EC-specific molecule-1 concentrations. What the implications are of these findings for clinical practice and/or further research? Endothelial cell-specific molecule-1 is not involved in the pathogenesis of E-PE. Moreover, advantageous and easy-to-measure markers are needed in larger sample studies to better understand the aetiology of E-PE. | |
| dc.identifier.doi | 10.1080/01443615.2020.1819215 | |
| dc.identifier.endpage | 898 | |
| dc.identifier.issn | 0144-3615 | |
| dc.identifier.issn | 1364-6893 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 33228435 | |
| dc.identifier.scopus | 2-s2.0-85096625276 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 893 | |
| dc.identifier.uri | https://doi.org/10.1080/01443615.2020.1819215 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/11051 | |
| dc.identifier.volume | 41 | |
| dc.identifier.wos | WOS:000591745200001 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Taylor & Francis Inc | |
| dc.relation.ispartof | Journal of Obstetrics and Gynaecology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Biomarker | |
| dc.subject | cardiovascular diseases | |
| dc.subject | endocan | |
| dc.subject | endothelial cell activation | |
| dc.subject | endothelial dysfunction | |
| dc.subject | predict | |
| dc.title | Maternal serum endothelial cell-specific molecule-1 level and its correlation with severity of early-onset preeclampsia | |
| dc.type | Article |










